Alexandria, VA – September 27, 2022 – The Innovation and Value Initiative (IVI), a non-profit research organization committed to advancing the science, practice, and use of value assessment in health care, today announced the 3rd Annual IVI Methods Summit to take place on Thursday, October 6, 2022 from 10:00 AM – 2:00 PM ET.

This one-day complimentary virtual event will explore the challenges, emerging solutions, and research opportunities around how the U.S. addresses innovation in the context of value. The forum will showcase multi-stakeholder perspectives on the opportunities and challenges that innovation in biopharmaceutical, digital, diagnostic, and delivery arenas present for the science and practice of value assessment/health technology assessment.

Speakers include:

  • Dr. Michelle McMurry-Heath, President and CEO, BIO
  • Lou Garrison, PhD., Professor Emeritus, Department of Pharmacy, University of Washington
  • Tiffany Westrich-Robertson, CEO and Co-Founder, AiArthritis
  • Samuel Peaseah, PhD, MBA, RPh, Senior Advisor, UPMC

For a full list of of speakers, please see here.

Attendees will include patient, family, and caregiver organizations; employer-purchaser and payer entities; researchers; value assessors and their supporting analytical research entities; investors; policymakers; and representatives from innovators across health technology.

If you are interested in attending, please register for your complimentary pass here.

View the event agenda here.

The 2022 IVI Methods Summit is funded by contributions from IVI’s diverse membership and a grant support from PhRMA. This project includes three components: 2022 Methods Summit public forum, a one-day invitational expert roundtable, and a call for research papers that will receive IVI funding in 2023.


About IVI
The Innovation and Value Initiative (IVI) is a 501(c)(3) tax-exempt, non-profit research organization dedicated to advancing the science and improving the practice of value assessment through development of novel methods and the creation and application of enhanced value assessment models to support local decision-making needs in healthcare.

Contact: Tiffany Huth, MPH
Phone: 202.487.8057